financetom
Business
financetom
/
Business
/
Melar Acquisition I to Take Everli Public in $180 Million Merger Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Melar Acquisition I to Take Everli Public in $180 Million Merger Deal
Jul 31, 2025 9:55 AM

12:39 PM EDT, 07/31/2025 (MT Newswires) -- Melar Acquisition I (MACI), a special purpose acquisition company, and Everli said Thursday that they have entered a merger agreement to take Everli public.

The deal gives Everli a pre-money valuation of $180 million, which could rise if the Italian e-grocery platform secures additional funding before the merger closes.

Once the transaction closes, the combined company will be called Everli Global Holdings and will aim to list on the Nasdaq under the ticker "EVRL." Per the deal, Everli will become a wholly owned subsidiary of Melar.

Both companies' boards have approved the proposed merger. It is still tied to shareholder approval and is expected to close in late 2025 or early 2026, though there's no guarantee on timing, the companies added.

Price: 10.47, Change: -0.08, Percent Change: -0.76

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Claros Mortgage Trust Keeps Quarterly Dividend at $0.25 Per Share; Payable July 15 to Shareholders of Record June 28
--Claros Mortgage Trust Keeps Quarterly Dividend at $0.25 Per Share; Payable July 15 to Shareholders of Record June 28
Jun 14, 2024
04:43 PM EDT, 06/14/2024 (MT Newswires) -- Price: 8.09, Change: +0.01, Percent Change: +0.12 ...
Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer
Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer
Jun 14, 2024
04:43 PM EDT, 06/14/2024 (MT Newswires) -- Amgen ( AMGN ) said late Friday the US Food and Drug Administration has cleared Blincyto to treat adults and children one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia, an aggressive type of blood cancer. The FDA approval, which is the third indication for Blincyto, covers people with...
Dream Finders Homes Insider Sold Shares Worth $568,433, According to a Recent SEC Filing
Dream Finders Homes Insider Sold Shares Worth $568,433, According to a Recent SEC Filing
Jun 14, 2024
04:42 PM EDT, 06/14/2024 (MT Newswires) -- Patrick O. Zalupski, 10% Owner, Director, President and CEO, on June 12, 2024, sold 20,596 shares in Dream Finders Homes ( DFH ) for $568,433. Following the Form 4 filing with the SEC, Zalupski has control over a total of 60,449,919 shares of the company, with 59,044,352 shares held directly and 1,405,567 controlled...
Zurn Elkay Water Solutions Insider Sold Shares Worth $6,123,256, According to a Recent SEC Filing
Zurn Elkay Water Solutions Insider Sold Shares Worth $6,123,256, According to a Recent SEC Filing
Jun 14, 2024
04:35 PM EDT, 06/14/2024 (MT Newswires) -- April Jalazo, 10% Owner, on June 12, 2024, sold 194,081 shares in Zurn Elkay Water Solutions ( ZWS ) for $6,123,256. Following the Form 4 filing with the SEC, Jalazo has control over a total of 24,125,339 shares of the company, with 24,125,339 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1439288/000110465924071788/xslF345X03/tm2417331-2_4seq1.xml Price: 30.62, Change: +0.02, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved